The first thing Promise Bio CEO Ronel Veksler wants you to know about the biotech company he co-founded, is that it’s not another AI drug discovery company. Instead, he’s looking to bring precision medicine to autoimmune diseases. Tel Aviv-based Promise Bio has developed a cloud-based AI platform that can spot different Post-Translational Modifications (PTMs) in […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Source: TECCRUCH
スポンサーリンク
Promise Bio exits stealth backed by Pfizer and AstraZeneca
IT起業ニュース
コメント